PHC Holdings Corporation

About Us
Group Companies
Products & Services
CSR
Investor Relations
Newsroom

About Us

Corporate Overview History Mission Vision Values Value Creation Plan Leadership

Group Companies

Ascensia LSI Medience Wemex Epredia PHCbi

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

PEOPLE INSIGHTS

ENVIRONMENTAL SUSTAINABILITY

Environmental Activities

SOCIAL RESPONSIBILITY

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

IR LIBRARY

STOCK INFORMATION

IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

Careers Contact

JP

Other PHC Group Websites

Other PHC Group Websites

Careers Contact JP

News

2022

Select year
- All view
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015

PHC
Holdings Corporation
Group Companies

Dec.2 News: Announcement of Resignation and Change in Role of Corporate Officer at PHC Holdings Corporation
Dec.1 News: Announcement of New Assignment of Corporate Officer at PHC Holdings Corporation Effective January 1, 2023
Nov.16 News: PHC Group Releases Newly Revised Mid-Term Plan, the "Value Creation Plan," Outlining Changes for FY2025 to Accelerate Growth by Advancing Value-Based Healthcare
Nov.16 IR: Notice of establishment of a new company and the integration (company split/absorption-type merger) of Medical Information Systems (Medicom) Business Unit, PHC Corporation and PHC Medicom Corporation which are wholly-owned subsidiaries of PHC Holdings Corporation
Sep.1 News: Announcement of Changes in Corporate Officer Area of Responsibility at PHC Holdings Corporation Effective September 1, 2022
Aug.12 News: Announcement of Resignation of Corporate Officer at PHC Holdings Corporation and New Assignment at PHC Group Subsidiary
Jun.29 News: Announcement of Changes in Board Members and Audit and Supervisory Board Member at PHC Holdings Corporation Effective June 29 and July 1, 2022
Jun.13 News: Announcement of Changes in Corporate Officers at PHC Holdings Corporation Effective June 13 and July 1, 2022
Jun.13 News: Announcement of Resignation of a Corporate Officer at PHC Holdings Corporation Effective June 1, 2022
May.25 IR: Notice regarding the Early Retirement Program at PHC Holdings Corporation and the consolidated subsidiaries
May.25 News: Announcement of Changes to Board of Directors at PHC Holdings Corporation Effective June 29 and July 1
May.12 IR: PHC Holdings Corporation Announces FY21 Full-Year Results and FY22 Forecast
Apr.28 News: PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer
Apr.22 News: Resignation of Independent External Director of PHC Holdings Corporation
Apr.4 News: Resignation of Independent External Director of PHC Holdings Corporation
Jan.19 News: Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022

Dec.23 CorporatePHC: Announcement of New Assignment and Change in Role of Board Member at PHC Corporation Effective January 1, 2023
Dec.2 CorporatePHC: Announcement of Resignation and New Appointment of a President at PHC Corporation Effective December 31, 2022 and January 1, 2023
Nov.8 ProductsAscensia: Ascensia Diabetes Care Announces Global Integration of The Eversense CGM System with Apple Health
Nov.3 ProductsAscensia: Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense^® E3 Continuous Glucose Monitoring System (CGM)
Nov.2 ProductsAscensia: Ascensia Launches The GlucoContro.Online Diabetes Management and Analytics Platform in The U.S.
Oct.10 ProductsAscensia: Ascensia Diabetes Care Completes Initial European Launch of The Next-Generation Eversense E3 Continuous Glucose Monitoring System
Sep.27 CorporateAscensia: Ascensia Diabetes Care Relaunches Successful ‘This is Diabetes’ Competition in Support of IDF’s World Diabetes Day
Sep.12 ProductsMedicom: Launch of Pilot Program Targeting Residents in Condominiums for an Online Medical Check-Up Program - Using Virtual Care Device Teladoc HEALTH and Activity Tracker MOTHER Bracelet
Sep.5 CorporateEpredia: Epredia Expands Anatomical Pathology Business in Europe with Acquisition of Microm Microtech France and Laurypath
Aug.30 ProductsEpredia: Epredia Launches Laser Cassette Printers Designed to Improve Sample Tracking and Laboratory Efficiency
Aug.8 ProductsPHC IVD: PHC IVD and JCR Announces Upgraded Medication Management App Melon Nikki™ for Pediatric Patients Undergoing Growth Hormone Therapy
Jul.26 ProductsPHCbi: PHCbi Develops First Prototype for Live Cell Metabolic Analysis, Paving the Way for Advances in Cell Therapy and Gene Therapy
Jun.27 CorporatePHC: Announcement of Changes in Board Members at PHC Corporation Effective June 27, 2022
Jun.16 ProductsAscensia: Ascensia Diabetes Care Announces European Approval of the Next-Generation Eversense E3 Continuous Glucose Monitoring System
May.25 CorporatePHC: Announcement of New Appointment of a Director at PHC Corporation Effective on June 27, 2022
May.2 ProductsAscensia: Ascensia Diabetes Care Presents New Research Showing that People Using the CONTOUR® Blood Glucose Monitoring System and App Experience Fewer Out-of-Target Blood Glucose levels
Apr.18 ProductsPHC IVD: PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions
Apr.4 ProductsAscensia: Ascensia Diabetes Care Launches the 6 Month Eversense® E3 Continuous Glucose Monitoring System in the U.S. with the New Eversense Pass Savings Program
Mar.1 ProductsAscensia: Ascensia Diabetes Care Launches the Eversense® Now Remote Monitoring App for Android Users in Europe
Feb.14 ProductsAscensia: Ascensia Diabetes Care Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months
Feb.14 CorporateAscensia: Ascensia Diabetes Care Proudly Supports Spare a Rose Campaign for Fifth Consecutive Year